Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Misty R Jenkins

Showing results (1-10 of 48) with videos related to

Pageof 5
Sort By:
Cancers|August 27, 2021
Identification and Targeting of Mutant Peptide Neoantigens in Cancer ImmunotherapyDaniel J Verdon, Misty R Jenkins
Current Opinion in Immunology|March 16, 2010
The synapse and cytolytic machinery of cytotoxic T cellsMisty R Jenkins, Gillian M Griffiths
Oncoscience|June 2, 2018
Programming a serial killer: CAR T cells form non-classical immune synapsesAlexander J Davenport, Misty R Jenkins
The New England Journal of Medicine|April 10, 2024
CAR T-Cell Therapy for GlioblastomaMisty R Jenkins, Katharine J Drummond
Oncoimmunology|September 26, 2015
Perforin-dependent cytotoxicity: 'Kiss of death' or prolonged embrace with darker elocation-idnseque11es?Joseph A Trapani, Ilia Voskoboinik, Misty R Jenkins
International Journal of Molecular Sciences|October 8, 2020
Cellular and Molecular Mechanisms of CD8<sup>+</sup> T Cell Differentiation, Dysfunction and ExhaustionDaniel J Verdon, Matthias Mulazzani, Misty R Jenkins
Molecular Oncology|April 1, 2023
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapyKrishneel Prasad, Ryan S Cross, Misty R Jenkins
Nature Reviews. Immunology|March 6, 2026
Progress in the development of cytokine armoured CAR T cellsKrishneel Prasad, Ryan S Cross, Misty R Jenkins
International Journal of Molecular Sciences|January 18, 2020
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection ImmunotherapiesRebecca C Abbott, Ryan S Cross, Misty R Jenkins
Journal for Immunotherapy of Cancer|April 5, 2022
To go or not to go? Biological logic gating engineered T cellsRebecca C Abbott, Hannah E Hughes-Parry, Misty R Jenkins
Pageof 5

Showing results (1-10 of 48) with videos related to

Sort By:
Pageof 5
Cancers|August 27, 2021
Identification and Targeting of Mutant Peptide Neoantigens in Cancer ImmunotherapyDaniel J Verdon, Misty R Jenkins
Current Opinion in Immunology|March 16, 2010
The synapse and cytolytic machinery of cytotoxic T cellsMisty R Jenkins, Gillian M Griffiths
Oncoscience|June 2, 2018
Programming a serial killer: CAR T cells form non-classical immune synapsesAlexander J Davenport, Misty R Jenkins
The New England Journal of Medicine|April 10, 2024
CAR T-Cell Therapy for GlioblastomaMisty R Jenkins, Katharine J Drummond
Oncoimmunology|September 26, 2015
Perforin-dependent cytotoxicity: 'Kiss of death' or prolonged embrace with darker elocation-idnseque11es?Joseph A Trapani, Ilia Voskoboinik, Misty R Jenkins
International Journal of Molecular Sciences|October 8, 2020
Cellular and Molecular Mechanisms of CD8<sup>+</sup> T Cell Differentiation, Dysfunction and ExhaustionDaniel J Verdon, Matthias Mulazzani, Misty R Jenkins
Molecular Oncology|April 1, 2023
Synthetic biology, genetic circuits and machine learning: a new age of cancer therapyKrishneel Prasad, Ryan S Cross, Misty R Jenkins
Nature Reviews. Immunology|March 6, 2026
Progress in the development of cytokine armoured CAR T cellsKrishneel Prasad, Ryan S Cross, Misty R Jenkins
International Journal of Molecular Sciences|January 18, 2020
Finding the Keys to the CAR: Identifying Novel Target Antigens for T Cell Redirection ImmunotherapiesRebecca C Abbott, Ryan S Cross, Misty R Jenkins
Journal for Immunotherapy of Cancer|April 5, 2022
To go or not to go? Biological logic gating engineered T cellsRebecca C Abbott, Hannah E Hughes-Parry, Misty R Jenkins
Pageof 5